Immuneering Corp - Ordinary Shares Class A Split history
Immuneering Corp - Ordinary Shares Class A has not split the face value of the share since Jan 1, 2000.
See all forthcoming SplitsImmuneering Corp - Ordinary Shares Class A Dividend history
Immuneering Corp - Ordinary Shares Class A has not given any dividends since Jan 1, 2000.
See all forthcoming dividendsBoard Meetings - Immuneering Corp - Ordinary Shares Class A
The next board meeting for Immuneering Corp - Ordinary Shares Class A is on 13 Nov 2025 for the purpose of Immuneering Corp Third Quarter Earnings Results for 2025
| Ex-Date | Purpose | Notes |
|---|---|---|
| 13 Nov 2025 | Immuneering Corp Third Quarter Earnings Results for 2025 | - |
| 29 Sep 2025 | Immuneering Corporation Phase 2a Data Update for IMM-1-104 in First-Line Pancreatic Cancer | - |
| 25 Sep 2025 | Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients | - |
| 13 Aug 2025 | Immuneering Corp Second Quarter Earnings Results for 2025 | - |
| 06 Aug 2025 | Immuneering Corp Second Quarter Earnings Results for 2025 | - |
| 17 Jun 2025 | Phase 2a Data Update for IMM-1-104 in First-Line Pancreatic Cancer | - |
| 13 Jun 2025 | Immuneering Corp Annual General Meeting for 2025 | - |
| 12 Jun 2025 | Immuneering Corp Annual General Meeting for 2025 | - |
| 07 May 2025 | Immuneering Corp First Quarter Earnings Results for 2025 | - |
| 05 May 2025 | Immuneering Corp First Quarter Earnings Results for 2025 | - |